-
1
-
-
0242270859
-
Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee
-
Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee
-
Wilson T.A., Rose S.R., Cohen P., et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J. Pediatr. 2003, 143:415-421. Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.
-
(2003)
J. Pediatr.
, vol.143
, pp. 415-421
-
-
Wilson, T.A.1
Rose, S.R.2
Cohen, P.3
-
2
-
-
0027445119
-
Adherence to treatment and health outcomes
-
Horwitz R.I., Horwitz S.M. Adherence to treatment and health outcomes. Arch. Intern. Med. 1993, 153:1863-1868.
-
(1993)
Arch. Intern. Med.
, vol.153
, pp. 1863-1868
-
-
Horwitz, R.I.1
Horwitz, S.M.2
-
3
-
-
33947501922
-
Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society
-
Clayton P.E., Cianfarani S., Czernichow P., Johannsson G., Rapaport R., Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J. Clin. Endocrinol. Metab. 2007, 92:804-810.
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, pp. 804-810
-
-
Clayton, P.E.1
Cianfarani, S.2
Czernichow, P.3
Johannsson, G.4
Rapaport, R.5
Rogol, A.6
-
4
-
-
0028889404
-
Growth in full-term small-for-gestational-age infants: from birth to final height
-
Karlberg J., Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr. Res. 1995, 38:733-939.
-
(1995)
Pediatr. Res.
, vol.38
, pp. 733-939
-
-
Karlberg, J.1
Albertsson-Wikland, K.2
-
5
-
-
0030049115
-
-
(Erratum in:)
-
Pediatr. Res. 1996, 39:175. (Erratum in:).
-
(1996)
Pediatr. Res.
, vol.39
, pp. 175
-
-
-
6
-
-
0030815994
-
Reduced final height and indications for insulin resistance in 20year olds born small for gestational age: regional cohort study
-
Leger J., Levy-Marchal C., Bloch J., et al. Reduced final height and indications for insulin resistance in 20year olds born small for gestational age: regional cohort study. BMJ 1997, 315:341-347.
-
(1997)
BMJ
, vol.315
, pp. 341-347
-
-
Leger, J.1
Levy-Marchal, C.2
Bloch, J.3
-
7
-
-
0031792808
-
Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1year's withdrawal
-
Leger J., Garel C., Fjellestad-Paulsen A., Hassan M., Czernichow P. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1year's withdrawal. J. Clin. Endocrinol. Metab. 1998, 83:3512-3516.
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, pp. 3512-3516
-
-
Leger, J.1
Garel, C.2
Fjellestad-Paulsen, A.3
Hassan, M.4
Czernichow, P.5
-
8
-
-
0030965815
-
The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age
-
Karlberg J.P., Albertsson-Wikland K., Kwan E.Y., Lam B.C., Low L.C. The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age. Horm. Res. 1997, 48(Suppl. 1):17-24.
-
(1997)
Horm. Res.
, vol.48
, Issue.SUPPL. 1
, pp. 17-24
-
-
Karlberg, J.P.1
Albertsson-Wikland, K.2
Kwan, E.Y.3
Lam, B.C.4
Low, L.C.5
-
9
-
-
0029115719
-
Children born small for gestational age: do they catch up?
-
Hokken-Koelega A.C., De Ridder M.A., Lemmen R.J., Den Hartog H., De Muinck Keizer-Schrama S.M., Drop S.L. Children born small for gestational age: do they catch up?. Pediatr. Res. 1995, 38:267-271.
-
(1995)
Pediatr. Res.
, vol.38
, pp. 267-271
-
-
Hokken-Koelega, A.C.1
De Ridder, M.A.2
Lemmen, R.J.3
Den Hartog, H.4
De Muinck Keizer-Schrama, S.M.5
Drop, S.L.6
-
10
-
-
78651456867
-
Auxological and metabolic study in small for gestational age children during 2years follow-up
-
Polo Perucchin P., Traggiai C., Calevo M.G., et al. Auxological and metabolic study in small for gestational age children during 2years follow-up. J. Matern.-Fetal Neonatal Med. 2011, 24:381-387.
-
(2011)
J. Matern.-Fetal Neonatal Med.
, vol.24
, pp. 381-387
-
-
Polo Perucchin, P.1
Traggiai, C.2
Calevo, M.G.3
-
11
-
-
3343026199
-
Turner syndrome: evaluation of prenatal diagnosis in 19 European registries
-
Baena N., De Vigan C., Cariati E., et al. Turner syndrome: evaluation of prenatal diagnosis in 19 European registries. Am. J. Med. Genet. A 2004, 15:16-20.
-
(2004)
Am. J. Med. Genet. A
, vol.15
, pp. 16-20
-
-
Baena, N.1
De Vigan, C.2
Cariati, E.3
-
12
-
-
0018069955
-
Spontaneous deaths of fetuses with chromosomal abnormalities diagnosed prenatally
-
Hook E.B. Spontaneous deaths of fetuses with chromosomal abnormalities diagnosed prenatally. N. Engl. J. Med. 1978, 299:1036-1038.
-
(1978)
N. Engl. J. Med.
, vol.299
, pp. 1036-1038
-
-
Hook, E.B.1
-
13
-
-
0025542292
-
Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark
-
Nielsen J., Wohlert M. Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig. Artic. Ser. 1990, 26:209-223.
-
(1990)
Birth Defects Orig. Artic. Ser.
, vol.26
, pp. 209-223
-
-
Nielsen, J.1
Wohlert, M.2
-
14
-
-
0035963921
-
Turner's syndrome
-
Ranke M.B., Saenger P. Turner's syndrome. Lancet 2001, 358:309-314.
-
(2001)
Lancet
, vol.358
, pp. 309-314
-
-
Ranke, M.B.1
Saenger, P.2
-
15
-
-
27144487822
-
Improved final height with long-term growth hormone treatment in Noonan syndrome
-
Osio D., Dahlgren J., Wikland K.A., Westphal O. Improved final height with long-term growth hormone treatment in Noonan syndrome. Acta Paediatr. 2005, 94:1232-1237.
-
(2005)
Acta Paediatr.
, vol.94
, pp. 1232-1237
-
-
Osio, D.1
Dahlgren, J.2
Wikland, K.A.3
Westphal, O.4
-
17
-
-
0028077697
-
Mapping a gene for Noonan syndrome to the long arm of chromosome 12
-
Jamieson C.R., van der Burgt I., Brady A.F., et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat. Genet. 1994, 8:357-360.
-
(1994)
Nat. Genet.
, vol.8
, pp. 357-360
-
-
Jamieson, C.R.1
van der Burgt, I.2
Brady, A.F.3
-
18
-
-
18444401014
-
Noonan syndrome and related disorders: genetics and pathogenesis
-
Tartaglia M., Gelb B.D. Noonan syndrome and related disorders: genetics and pathogenesis. Annu. Rev. Genomics Hum. Genet. 2005, 6:45-68.
-
(2005)
Annu. Rev. Genomics Hum. Genet.
, vol.6
, pp. 45-68
-
-
Tartaglia, M.1
Gelb, B.D.2
-
19
-
-
33845900943
-
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
-
Roberts A.E., Araki T., Swanson K.D., et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat. Genet. 2007, 39:70-74.
-
(2007)
Nat. Genet.
, vol.39
, pp. 70-74
-
-
Roberts, A.E.1
Araki, T.2
Swanson, K.D.3
-
20
-
-
34547530823
-
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
-
Pandit B., Sarkozy A., Pennacchio L.A., et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat. Genet. 2007, 39:1007-1012.
-
(2007)
Nat. Genet.
, vol.39
, pp. 1007-1012
-
-
Pandit, B.1
Sarkozy, A.2
Pennacchio, L.A.3
-
21
-
-
80055098242
-
Spectrum of mutations in Noonan syndrome and their correlation with phenotypes
-
[Epub ahead of print]
-
Lee B.H., Kim J.M., Jin H.Y., Kim G.H., Choi J.H., Yoo H.W. Spectrum of mutations in Noonan syndrome and their correlation with phenotypes. J. Pediatr. 2011, (July 22). [Epub ahead of print].
-
(2011)
J. Pediatr.
, Issue.2
-
-
Lee, B.H.1
Kim, J.M.2
Jin, H.Y.3
Kim, G.H.4
Choi, J.H.5
Yoo, H.W.6
-
22
-
-
0024238928
-
Noonan syndrome: growth and clinical manifestations in 144 cases
-
Ranke M.B., Heidemann P., Knupfer C., Enders H., Schmaltz A.A., Bierich J.R. Noonan syndrome: growth and clinical manifestations in 144 cases. Eur. J. Pediatr. 1988, 148:220-227.
-
(1988)
Eur. J. Pediatr.
, vol.148
, pp. 220-227
-
-
Ranke, M.B.1
Heidemann, P.2
Knupfer, C.3
Enders, H.4
Schmaltz, A.A.5
Bierich, J.R.6
-
23
-
-
0000040232
-
Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society
-
Growth Hormone Research Society
-
Growth Hormone Research Society Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J. Clin. Endocrinol. Metab. 2000, 85:3990-3993.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 3990-3993
-
-
-
24
-
-
0036772809
-
Diagnosis and management of growth hormone deficiency in childhood and adolescence - part 2: growth hormone treatment in growth hormone deficient children
-
Tanaka T., Cohen P., Clayton P.E., Laron Z., Hintz R.L., Sizonenko P.C. Diagnosis and management of growth hormone deficiency in childhood and adolescence - part 2: growth hormone treatment in growth hormone deficient children. Growth Horm. IGF Res. 2002, 12:323-341.
-
(2002)
Growth Horm. IGF Res.
, vol.12
, pp. 323-341
-
-
Tanaka, T.1
Cohen, P.2
Clayton, P.E.3
Laron, Z.4
Hintz, R.L.5
Sizonenko, P.C.6
-
25
-
-
0029085354
-
Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children
-
Boguszewski M., Rosberg S., Albertsson-Wikland K. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J. Clin. Endocrinol. Metab. 1995, 80:2599-2606.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 2599-2606
-
-
Boguszewski, M.1
Rosberg, S.2
Albertsson-Wikland, K.3
-
26
-
-
70649088097
-
Changes in GH/IGF-1 axis in intrauterine growth retardation: consequences of fetal programming?
-
Setia S., Sridhar M.G. Changes in GH/IGF-1 axis in intrauterine growth retardation: consequences of fetal programming?. Horm. Metab. Res. 2009, 41:791-798.
-
(2009)
Horm. Metab. Res.
, vol.41
, pp. 791-798
-
-
Setia, S.1
Sridhar, M.G.2
-
27
-
-
35848943502
-
Growth hormone therapy for short children born small for gestational age
-
Chatelain P., Carrascosa A., Bona G., Ferrandez-Longas A., Sippell W. Growth hormone therapy for short children born small for gestational age. Horm. Res. 2007, 68:300-309.
-
(2007)
Horm. Res.
, vol.68
, pp. 300-309
-
-
Chatelain, P.1
Carrascosa, A.2
Bona, G.3
Ferrandez-Longas, A.4
Sippell, W.5
-
28
-
-
0038699006
-
Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study
-
Carel J.C., Chatelain P., Rochiccioli P., Chaussain J.L. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. J. Clin. Endocrinol. Metab. 2003, 88:1587-1593.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 1587-1593
-
-
Carel, J.C.1
Chatelain, P.2
Rochiccioli, P.3
Chaussain, J.L.4
-
29
-
-
0041883362
-
Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial
-
van Pareren Y., Mulder P., Houdijk M., Jansen M., Reeser M., Hokken-Koelega A. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J. Clin. Endocrinol. Metab. 2003, 88:3584-3590.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 3584-3590
-
-
van Pareren, Y.1
Mulder, P.2
Houdijk, M.3
Jansen, M.4
Reeser, M.5
Hokken-Koelega, A.6
-
30
-
-
0034864154
-
Treatment with growth hormone in short children born with intrauterine growth retardation
-
Czernichow P. Treatment with growth hormone in short children born with intrauterine growth retardation. Endocrine 2001, 15:39-42.
-
(2001)
Endocrine
, vol.15
, pp. 39-42
-
-
Czernichow, P.1
-
31
-
-
0033305332
-
Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial
-
Sas T., de Waal W., Mulder P., et al. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J. Clin. Endocrinol. Metab. 1999, 84:3064-3070.
-
(1999)
J. Clin. Endocrinol. Metab.
, vol.84
, pp. 3064-3070
-
-
Sas, T.1
de Waal, W.2
Mulder, P.3
-
32
-
-
56749097072
-
European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens
-
European Norditropin SGA Study Group
-
Phillip M., Lebenthal Y., Lebl J., et al. European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens. Horm. Res. 2009, 71:52-59. European Norditropin SGA Study Group.
-
(2009)
Horm. Res.
, vol.71
, pp. 52-59
-
-
Phillip, M.1
Lebenthal, Y.2
Lebl, J.3
-
33
-
-
0029820179
-
Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age
-
Boguszewski M., Jansson C., Rosberg S., Albertsson-Wikland K. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J. Clin. Endocrinol. Metab. 1996, 81:3902-3908.
-
(1996)
J. Clin. Endocrinol. Metab.
, vol.81
, pp. 3902-3908
-
-
Boguszewski, M.1
Jansson, C.2
Rosberg, S.3
Albertsson-Wikland, K.4
-
34
-
-
0036145971
-
High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity
-
de Zegher F., Ong K., van Helvoirt M., Mohn A., Woods K., Dunger D. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity. J. Clin. Endocrinol. Metab. 2002, 87:148-151.
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, pp. 148-151
-
-
de Zegher, F.1
Ong, K.2
van Helvoirt, M.3
Mohn, A.4
Woods, K.5
Dunger, D.6
-
35
-
-
10744222957
-
GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial
-
Arends N.J., Boonstra V.H., Mulder P.G., et al. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial. Clin. Endocrinol. (Oxf.) 2003, 59:779-787.
-
(2003)
Clin. Endocrinol. (Oxf.)
, vol.59
, pp. 779-787
-
-
Arends, N.J.1
Boonstra, V.H.2
Mulder, P.G.3
-
36
-
-
1542313860
-
Effect of different growth hormone dosages on the growth velocity in children born small for gestational age
-
Bozzola E., Lauriola S., Messina M.F., Bona G., Tinelli C., Tatò L. Effect of different growth hormone dosages on the growth velocity in children born small for gestational age. Horm. Res. 2004, 61:98-102.
-
(2004)
Horm. Res.
, vol.61
, pp. 98-102
-
-
Bozzola, E.1
Lauriola, S.2
Messina, M.F.3
Bona, G.4
Tinelli, C.5
Tatò, L.6
-
37
-
-
22544440483
-
Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term
-
de Zegher F., Hokken-Koelega A. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. Pediatrics 2005, 115:e458-e462.
-
(2005)
Pediatrics
, vol.115
-
-
de Zegher, F.1
Hokken-Koelega, A.2
-
38
-
-
0037241082
-
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)
-
KIGS International Board
-
Ranke M.B., Lindberg A., Cowell C.T., et al. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J. Clin. Endocrinol. Metab. 2003, 88:125-131. KIGS International Board.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 125-131
-
-
Ranke, M.B.1
Lindberg, A.2
Cowell, C.T.3
-
39
-
-
12844263377
-
Final height in short children born small for gestational age treated with growth hormone
-
Dahlgren J., Wikland K.A. Final height in short children born small for gestational age treated with growth hormone. Pediatr. Res. 2005, 57:216-222.
-
(2005)
Pediatr. Res.
, vol.57
, pp. 216-222
-
-
Dahlgren, J.1
Wikland, K.A.2
-
40
-
-
0034458088
-
Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6years
-
de Zegher F., Albertsson-Wikland K., Wollmann H.A., et al. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6years. J. Clin. Endocrinol. Metab. 2000, 85:2816-2821.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 2816-2821
-
-
de Zegher, F.1
Albertsson-Wikland, K.2
Wollmann, H.A.3
-
41
-
-
0033756754
-
Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency
-
Sas T., Mulder P., Hokken-Koelega A. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J. Clin. Endocrinol. Metab. 2000, 85:3786-3792.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 3786-3792
-
-
Sas, T.1
Mulder, P.2
Hokken-Koelega, A.3
-
42
-
-
0034492473
-
Body proportions during 6 years of GH treatment in children with short stature born small for gestational age participating in a randomised, double-blind, dose-response trial
-
Sas T.C., Gerver W.J., De Bruin R., et al. Body proportions during 6 years of GH treatment in children with short stature born small for gestational age participating in a randomised, double-blind, dose-response trial. Clin. Endocrinol. (Oxf.) 2000, 53:675-681.
-
(2000)
Clin. Endocrinol. (Oxf.)
, vol.53
, pp. 675-681
-
-
Sas, T.C.1
Gerver, W.J.2
De Bruin, R.3
-
43
-
-
34547765996
-
Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age
-
Bannink E.M., van Doorn J., Mulder P.G., Hokken-Koelega A.C. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age. J. Clin. Endocrinol. Metab. 2007, 92:2992-3000.
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, pp. 2992-3000
-
-
Bannink, E.M.1
van Doorn, J.2
Mulder, P.G.3
Hokken-Koelega, A.C.4
-
44
-
-
33846094114
-
Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls
-
van Dijk M., Bannink E.M., van Pareren Y.K., Mulder P.G., Hokken-Koelega A.C. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls. J. Clin. Endocrinol. Metab. 2007, 92:160-165.
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, pp. 160-165
-
-
van Dijk, M.1
Bannink, E.M.2
van Pareren, Y.K.3
Mulder, P.G.4
Hokken-Koelega, A.C.5
-
45
-
-
70349254743
-
Impact of growth hormone therapy on adult height of children born small for gestational age
-
Maiorana A., Cianfarani S. Impact of growth hormone therapy on adult height of children born small for gestational age. Pediatrics 2009, 124:e519-e531.
-
(2009)
Pediatrics
, vol.124
-
-
Maiorana, A.1
Cianfarani, S.2
-
46
-
-
61449233146
-
Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study
-
Jung H., Land C., Nicolay C., De Schepper J., Blum W.F., Schönau E. Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study. Eur. J. Endocrinol. 2009, 160:149-156.
-
(2009)
Eur. J. Endocrinol.
, vol.160
, pp. 149-156
-
-
Jung, H.1
Land, C.2
Nicolay, C.3
De Schepper, J.4
Blum, W.F.5
Schönau, E.6
-
47
-
-
15444361239
-
Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation
-
Fjellestad-Paulsen A., Czernichow P., Brauner R., et al. Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation. Acta Paediatr. 1998, 87:511-517.
-
(1998)
Acta Paediatr.
, vol.87
, pp. 511-517
-
-
Fjellestad-Paulsen, A.1
Czernichow, P.2
Brauner, R.3
-
48
-
-
0033305653
-
Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome
-
Kosho T., Muroya K., Nagai T., et al. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J. Clin. Endocrinol. Metab. 1999, 84:4613-4621.
-
(1999)
J. Clin. Endocrinol. Metab.
, vol.84
, pp. 4613-4621
-
-
Kosho, T.1
Muroya, K.2
Nagai, T.3
-
49
-
-
0033304838
-
Growth retardation in Turner syndrome: aneuploidy, rather than specific gene loss, may explain growth failure
-
Haverkamp F., Wölfle J., Zerres K., et al. Growth retardation in Turner syndrome: aneuploidy, rather than specific gene loss, may explain growth failure. J. Clin. Endocrinol. Metab. 1999, 84:4578-4582.
-
(1999)
J. Clin. Endocrinol. Metab.
, vol.84
, pp. 4578-4582
-
-
Haverkamp, F.1
Wölfle, J.2
Zerres, K.3
-
50
-
-
0031991527
-
Growth hormone therapy of Turner's syndrome: beneficial effect on adult height
-
Rosenfeld R.G., Attie K.M., Frane J., et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J. Pediatr. 1998, 132:319-324.
-
(1998)
J. Pediatr.
, vol.132
, pp. 319-324
-
-
Rosenfeld, R.G.1
Attie, K.M.2
Frane, J.3
-
51
-
-
0033305178
-
Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial
-
Sas T.C., de Muinck Keizer-Schrama S.M., Stijnen T., et al. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J. Clin. Endocrinol. Metab. 1999, 84:4607-4612.
-
(1999)
J. Clin. Endocrinol. Metab.
, vol.84
, pp. 4607-4612
-
-
Sas, T.C.1
de Muinck Keizer-Schrama, S.M.2
Stijnen, T.3
-
52
-
-
0036920811
-
Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome
-
van Pareren Y.K., De Muinck Keizer-Schrama S.M., Stijnen T., Sas T.C., Drop S.L. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 2002, 87:5442-5448.
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, pp. 5442-5448
-
-
van Pareren, Y.K.1
De Muinck Keizer-Schrama, S.M.2
Stijnen, T.3
Sas, T.C.4
Drop, S.L.5
-
53
-
-
18344393262
-
Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height
-
Quigley C.A., Crowe B.J., Anglin D.G., Chipman J.J. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J. Clin. Endocrinol. Metab. 2002, 87:2033-2041.
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, pp. 2033-2041
-
-
Quigley, C.A.1
Crowe, B.J.2
Anglin, D.G.3
Chipman, J.J.4
-
54
-
-
0037340318
-
Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens
-
van Pareren Y.K., de Muinck Keizer-Schrama S.M., Stijnen T., et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J. Clin. Endocrinol. Metab. 2003, 88:1119-1125.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 1119-1125
-
-
van Pareren, Y.K.1
de Muinck Keizer-Schrama, S.M.2
Stijnen, T.3
-
55
-
-
0141787972
-
Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height
-
Belgian Study Group for Pediatric Endocrinology
-
Massa G., Heinrichs C., Verlinde S., et al. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. J. Clin. Endocrinol. Metab. 2003, 88:4168-4174. Belgian Study Group for Pediatric Endocrinology.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 4168-4174
-
-
Massa, G.1
Heinrichs, C.2
Verlinde, S.3
-
56
-
-
0034530904
-
Kabi International Growth Study, prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study
-
KIGS International Board
-
Ranke M.B., Lindberg A., Chatelain P., et al. Kabi International Growth Study, prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. J. Clin. Endocrinol. Metab. 2000, 85:4212-4218. KIGS International Board.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 4212-4218
-
-
Ranke, M.B.1
Lindberg, A.2
Chatelain, P.3
-
57
-
-
21244448056
-
Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian Randomized Controlled Trial
-
The Canadian Growth Hormone Advisory Committee.
-
The Canadian Growth Hormone Advisory Committee Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian Randomized Controlled Trial. J. Clin. Endocrinol. Metab. 2005, 90:3360-3366.
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, pp. 3360-3366
-
-
-
58
-
-
34548804590
-
Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial
-
Davenport M.L., Crowe B.J., Travers S.H., et al. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J. Clin. Endocrinol. Metab. 2007, 92:3406-3416.
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, pp. 3406-3416
-
-
Davenport, M.L.1
Crowe, B.J.2
Travers, S.H.3
-
59
-
-
17244381641
-
The role of insulin-like growth factor I monitoring in growth hormone-treated children
-
Park P., Cohen P. The role of insulin-like growth factor I monitoring in growth hormone-treated children. Horm. Res. 2004, 62(Suppl. 1):59-65.
-
(2004)
Horm. Res.
, vol.62
, Issue.SUPPL. 1
, pp. 59-65
-
-
Park, P.1
Cohen, P.2
-
60
-
-
77749315758
-
Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome
-
Menke L.A., Sas T.C., de Muinck Keizer-Schrama S.M., et al. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. J. Clin. Endocrinol. Metab. 2010, 95:1151-1160.
-
(2010)
J. Clin. Endocrinol. Metab.
, vol.95
, pp. 1151-1160
-
-
Menke, L.A.1
Sas, T.C.2
de Muinck Keizer-Schrama, S.M.3
-
61
-
-
0026630454
-
Noonan syndrome presenting growth hormone neurosecretory dysfunction
-
Tanaka K., Sato A., Naito T., Kuramochi K., Itabashi H., Takemura Y. Noonan syndrome presenting growth hormone neurosecretory dysfunction. Intern. Med. 1992, 31:908-911.
-
(1992)
Intern. Med.
, vol.31
, pp. 908-911
-
-
Tanaka, K.1
Sato, A.2
Naito, T.3
Kuramochi, K.4
Itabashi, H.5
Takemura, Y.6
-
62
-
-
0026073598
-
Noonan's syndrome: abnormalities of the growth hormone/IGF-I axis and the response to treatment with human biosynthetic growth hormone
-
Ahmed M.L., Foot A.B., Edge J.A., Lamkin V.A., Savage M.O., Dunger D.B. Noonan's syndrome: abnormalities of the growth hormone/IGF-I axis and the response to treatment with human biosynthetic growth hormone. Acta Paediatr. Scand. 1991, 80:446-450.
-
(1991)
Acta Paediatr. Scand.
, vol.80
, pp. 446-450
-
-
Ahmed, M.L.1
Foot, A.B.2
Edge, J.A.3
Lamkin, V.A.4
Savage, M.O.5
Dunger, D.B.6
-
63
-
-
0029865254
-
Growth hormone treatment in Noonan syndrome: the National Cooperative Growth Study experience
-
Romano A.A., Blethen S.L., Dana K., Noto R.A. Growth hormone treatment in Noonan syndrome: the National Cooperative Growth Study experience. J. Pediatr. 1996, 128:S18-S21.
-
(1996)
J. Pediatr.
, vol.128
-
-
Romano, A.A.1
Blethen, S.L.2
Dana, K.3
Noto, R.A.4
-
64
-
-
0035008529
-
Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up
-
Macfarlane C.E., Brown D.C., Johnston L.B., et al. Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up. J. Clin. Endocrinol. Metab. 2001, 86:1953-1956.
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 1953-1956
-
-
Macfarlane, C.E.1
Brown, D.C.2
Johnston, L.B.3
-
65
-
-
42449084089
-
Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database
-
Raaijmakers R., Noordam C., Karagiannis G., et al. Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database. J. Pediatr. Endocrinol. Metab. 2008, 21:267-273.
-
(2008)
J. Pediatr. Endocrinol. Metab.
, vol.21
, pp. 267-273
-
-
Raaijmakers, R.1
Noordam, C.2
Karagiannis, G.3
-
66
-
-
0035021887
-
Short stature in Noonan syndrome: response to growth hormone therapy
-
Group tU
-
Kirk J.M., Betts P.R., Butler G.E., et al. Short stature in Noonan syndrome: response to growth hormone therapy. Arch. Dis. Child. 2001, 84:440-443. Group tU.
-
(2001)
Arch. Dis. Child.
, vol.84
, pp. 440-443
-
-
Kirk, J.M.1
Betts, P.R.2
Butler, G.E.3
-
67
-
-
53249131216
-
Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11
-
Noordam C., Peer P.G., Francois I., De Schepper J., van den Burgt I., Otten B.J. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11. Eur. J. Endocrinol. 2008, 159:203-208.
-
(2008)
Eur. J. Endocrinol.
, vol.159
, pp. 203-208
-
-
Noordam, C.1
Peer, P.G.2
Francois, I.3
De Schepper, J.4
van den Burgt, I.5
Otten, B.J.6
-
68
-
-
73849105803
-
GH therapy in Noonan syndrome: review of final height data
-
Dahlgren J. GH therapy in Noonan syndrome: review of final height data. Horm. Res. 2009, 72(Suppl. 2):46-48.
-
(2009)
Horm. Res.
, vol.72
, Issue.SUPPL. 2
, pp. 46-48
-
-
Dahlgren, J.1
-
69
-
-
67650263893
-
Growth response, near-adult height, and patterns of growth and puberty in patients with Noonan syndrome treated with growth hormone
-
Romano A.A., Dana K., Bakker B., et al. Growth response, near-adult height, and patterns of growth and puberty in patients with Noonan syndrome treated with growth hormone. J. Clin. Endocrinol. Metab. 2009, 94:2338-2344.
-
(2009)
J. Clin. Endocrinol. Metab.
, vol.94
, pp. 2338-2344
-
-
Romano, A.A.1
Dana, K.2
Bakker, B.3
-
70
-
-
39049160669
-
Growth hormone treatment and fat redistribution in children born small for gestational age
-
De Schepper J., Thomas M., Beckers D., Craen M., Maes M., de Zegher F. Growth hormone treatment and fat redistribution in children born small for gestational age. J. Pediatr. 2008, 152:327-330.
-
(2008)
J. Pediatr.
, vol.152
, pp. 327-330
-
-
De Schepper, J.1
Thomas, M.2
Beckers, D.3
Craen, M.4
Maes, M.5
de Zegher, F.6
-
71
-
-
31744448841
-
Food intake of children with short stature born small for gestational age before and during a randomized GH trial
-
Boonstra V.H., Arends N.J., Stijnen T., Blum W.F., Akkerman O., Hokken-Koelega A.C. Food intake of children with short stature born small for gestational age before and during a randomized GH trial. Horm. Res. 2006, 65:23-30.
-
(2006)
Horm. Res.
, vol.65
, pp. 23-30
-
-
Boonstra, V.H.1
Arends, N.J.2
Stijnen, T.3
Blum, W.F.4
Akkerman, O.5
Hokken-Koelega, A.C.6
-
72
-
-
77952777084
-
Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin
-
Ibáñez L., Lopez-Bermejo A., Díaz M., Jaramillo A., Marín S., de Zegher F. Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin. J. Clin. Endocrinol. Metab. 2010, 95:2234-2239.
-
(2010)
J. Clin. Endocrinol. Metab.
, vol.95
, pp. 2234-2239
-
-
Ibáñez, L.1
Lopez-Bermejo, A.2
Díaz, M.3
Jaramillo, A.4
Marín, S.5
de Zegher, F.6
-
73
-
-
73949159311
-
The PPAR-gamma Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age
-
de Kort S.W., Hokken-Koelega A.C. The PPAR-gamma Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age. Eur. J. Endocrinol. 2010, 162:49-52.
-
(2010)
Eur. J. Endocrinol.
, vol.162
, pp. 49-52
-
-
de Kort, S.W.1
Hokken-Koelega, A.C.2
-
74
-
-
33751539823
-
The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome
-
Ari M., Bakalov V.K., Hil S., Bondy C.A. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome. J. Clin. Endocrinol. Metab. 2006, 91:4302-4305.
-
(2006)
J. Clin. Endocrinol. Metab.
, vol.91
, pp. 4302-4305
-
-
Ari, M.1
Bakalov, V.K.2
Hil, S.3
Bondy, C.A.4
-
75
-
-
45149088442
-
Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome
-
Wooten N., Bakalov V.K., Hill S., Bondy C.A. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J. Clin. Endocrinol. Metab. 2008, 93:2109-2114.
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 2109-2114
-
-
Wooten, N.1
Bakalov, V.K.2
Hill, S.3
Bondy, C.A.4
-
76
-
-
0032956687
-
Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome. Dutch Working Group on Growth Hormone
-
van Teunenbroek A., de Muinck Keizer-Schrama S.M., Aanstoot H.J., Stijnen T., Hoogerbrugge N., Drop S.L. Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome. Dutch Working Group on Growth Hormone. Metabolism 1999, 48:7-14.
-
(1999)
Metabolism
, vol.48
, pp. 7-14
-
-
van Teunenbroek, A.1
de Muinck Keizer-Schrama, S.M.2
Aanstoot, H.J.3
Stijnen, T.4
Hoogerbrugge, N.5
Drop, S.L.6
-
77
-
-
34548662418
-
Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial
-
Willemsen R.H., Arends N.J., Bakker-van Waarde W.M., et al. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. Clin. Endocrinol. (Oxf.) 2007, 67:485-492.
-
(2007)
Clin. Endocrinol. (Oxf.)
, vol.67
, pp. 485-492
-
-
Willemsen, R.H.1
Arends, N.J.2
Bakker-van Waarde, W.M.3
-
78
-
-
84883204190
-
Bone mineral assessment in patients with Prader-Willi syndrome
-
Salles J., Lounis N., Diene G., Conte-Auriol F., Moulin P., Tauber M. Bone mineral assessment in patients with Prader-Willi syndrome. Bone 2007, 40(Suppl 1):275.
-
(2007)
Bone
, vol.40
, Issue.SUPPL 1
, pp. 275
-
-
Salles, J.1
Lounis, N.2
Diene, G.3
Conte-Auriol, F.4
Moulin, P.5
Tauber, M.6
-
79
-
-
35348913162
-
Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: a pQCT study of GH-deficient and small-for-gestational-age (SGA) children
-
Schweizer R., Martin D.D., Haase M., et al. Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: a pQCT study of GH-deficient and small-for-gestational-age (SGA) children. Bone 2007, 41:875-881.
-
(2007)
Bone
, vol.41
, pp. 875-881
-
-
Schweizer, R.1
Martin, D.D.2
Haase, M.3
-
80
-
-
33645330427
-
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy
-
Mazziotti G., Bianchi A., Bonadonna S., et al. Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 2006, 21:520-528.
-
(2006)
J. Bone Miner. Res.
, vol.21
, pp. 520-528
-
-
Mazziotti, G.1
Bianchi, A.2
Bonadonna, S.3
-
82
-
-
0142095035
-
Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency
-
Baroncelli G.I., Bertelloni S., Sodini F., Saggese G. Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency. J. Pediatr. Endocrinol. Metab. 2003, 16(Suppl. 2):327-335.
-
(2003)
J. Pediatr. Endocrinol. Metab.
, vol.16
, Issue.SUPPL. 2
, pp. 327-335
-
-
Baroncelli, G.I.1
Bertelloni, S.2
Sodini, F.3
Saggese, G.4
-
83
-
-
0036424524
-
The psychosocial consequences of short stature: a review of the evidence
-
Sandberg D.E., Voss L.D. The psychosocial consequences of short stature: a review of the evidence. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16:449-463.
-
(2002)
Best Pract. Res. Clin. Endocrinol. Metab.
, vol.16
, pp. 449-463
-
-
Sandberg, D.E.1
Voss, L.D.2
-
84
-
-
0028376749
-
Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study
-
Stabler B., Clopper R.R., Siegel P.T., Stoppani C., Compton P.G., Underwood L.E. Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. J. Dev. Behav. Pediatr. 1994, 15:1-6.
-
(1994)
J. Dev. Behav. Pediatr.
, vol.15
, pp. 1-6
-
-
Stabler, B.1
Clopper, R.R.2
Siegel, P.T.3
Stoppani, C.4
Compton, P.G.5
Underwood, L.E.6
-
85
-
-
11844293088
-
Height and social adjustment: are extremes a cause for concern and action?
-
Sandberg D.E., Bukowski W.M., Fung C.M., Noll R.B. Height and social adjustment: are extremes a cause for concern and action?. Pediatrics 2004, 114:744-750.
-
(2004)
Pediatrics
, vol.114
, pp. 744-750
-
-
Sandberg, D.E.1
Bukowski, W.M.2
Fung, C.M.3
Noll, R.B.4
-
86
-
-
8744282738
-
Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age
-
van Pareren Y.K., Duivenvoorden H.J., Slijper F.S., Koot H.M., Hokken-Koelega A.C. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age. J. Clin. Endocrinol. Metab. 2004, 89:5295-5302.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 5295-5302
-
-
van Pareren, Y.K.1
Duivenvoorden, H.J.2
Slijper, F.S.3
Koot, H.M.4
Hokken-Koelega, A.C.5
-
87
-
-
27844437212
-
Quality of life in adolescents born small for gestational age: does growth hormone make a difference?
-
Bannink E.M., van Pareren Y.K., Theunissen N.C., Raat H., Mulder P.G., Hokken-Koelega A.C. Quality of life in adolescents born small for gestational age: does growth hormone make a difference?. Horm. Res. 2005, 64:166-174.
-
(2005)
Horm. Res.
, vol.64
, pp. 166-174
-
-
Bannink, E.M.1
van Pareren, Y.K.2
Theunissen, N.C.3
Raat, H.4
Mulder, P.G.5
Hokken-Koelega, A.C.6
-
88
-
-
33747343922
-
Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment
-
Bannink E.M., van Doorn J., Stijnen T., Drop S.L., de Muinck Keizer-Schrama S.M. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Clin. Endocrinol. (Oxf.) 2006, 65:310-319.
-
(2006)
Clin. Endocrinol. (Oxf.)
, vol.65
, pp. 310-319
-
-
Bannink, E.M.1
van Doorn, J.2
Stijnen, T.3
Drop, S.L.4
de Muinck Keizer-Schrama, S.M.5
-
89
-
-
24344434575
-
Safety of growth hormone treatment in pediatric patients with idiopathic short stature
-
Quigley C.A., Gill A.M., Crowe B.J., et al. Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J. Clin. Endocrinol. Metab. 2005, 90:5188-5196.
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, pp. 5188-5196
-
-
Quigley, C.A.1
Gill, A.M.2
Crowe, B.J.3
-
90
-
-
44949248999
-
Recombinant growth hormone for idiopathic short stature in children and adolescents
-
Bryant J., Cave C., Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst. Rev. 2003, 4:CD004440.
-
(2003)
Cochrane Database Syst. Rev.
, vol.4
-
-
Bryant, J.1
Cave, C.2
Milne, R.3
-
93
-
-
0026008824
-
Fetal and infant growth and impaired glucose tolerance at age 64
-
Hales C.N., Barker D.J., Clark P.M., et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991, 303:1019-1022.
-
(1991)
BMJ
, vol.303
, pp. 1019-1022
-
-
Hales, C.N.1
Barker, D.J.2
Clark, P.M.3
-
94
-
-
0027513981
-
Fetal nutrition and cardiovascular disease in adult life
-
Barker D.J., Gluckman P.D., Godfrey K.M., Harding J.E., Owens J.A., Robinson J.S. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341:938-941.
-
(1993)
Lancet
, vol.341
, pp. 938-941
-
-
Barker, D.J.1
Gluckman, P.D.2
Godfrey, K.M.3
Harding, J.E.4
Owens, J.A.5
Robinson, J.S.6
-
95
-
-
0027529974
-
Type 2 (noninsulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth
-
Barker D.J., Hales C.N., Fall C.H., Osmond C., Phipps K., Clark P.M. Type 2 (noninsulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62-67.
-
(1993)
Diabetologia
, vol.36
, pp. 62-67
-
-
Barker, D.J.1
Hales, C.N.2
Fall, C.H.3
Osmond, C.4
Phipps, K.5
Clark, P.M.6
-
96
-
-
0036245664
-
Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence
-
Jeffcoate W. Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence. Drug Saf. 2002, 25:199-212.
-
(2002)
Drug Saf.
, vol.25
, pp. 199-212
-
-
Jeffcoate, W.1
-
97
-
-
66149101010
-
Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations
-
Friedrich N., Haring R., Nauck M., et al. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J. Clin. Endocrinol. Metab. 2009, 94:1732-1739.
-
(2009)
J. Clin. Endocrinol. Metab.
, vol.94
, pp. 1732-1739
-
-
Friedrich, N.1
Haring, R.2
Nauck, M.3
-
98
-
-
0036312704
-
Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study
-
Sklar C.A., Mertens A.C., Mitby P., et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J. Clin. Endocrinol. Metab. 2002, 87:3136-3141.
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, pp. 3136-3141
-
-
Sklar, C.A.1
Mertens, A.C.2
Mitby, P.3
-
99
-
-
33750080457
-
Cancers associated with acromegaly
-
Jenkins P.J. Cancers associated with acromegaly. Neuroendocrinology 2006, 83:218-223.
-
(2006)
Neuroendocrinology
, vol.83
, pp. 218-223
-
-
Jenkins, P.J.1
-
100
-
-
0345828935
-
Clinical pharmacological aspects of growth hormone administration
-
Laursen T. Clinical pharmacological aspects of growth hormone administration. Growth Horm. IGF Res. 2004, 14:16-44.
-
(2004)
Growth Horm. IGF Res.
, vol.14
, pp. 16-44
-
-
Laursen, T.1
-
101
-
-
0026014288
-
Human growth hormone replacement therapy: pharmacological and clinical aspects
-
Jørgensen J.O. Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr. Rev. 1991, 12:189-207.
-
(1991)
Endocr. Rev.
, vol.12
, pp. 189-207
-
-
Jørgensen, J.O.1
-
102
-
-
0029119736
-
Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients
-
Laursen T., Jørgensen J.O., Jakobsen G., Hansen B.L., Christiansen J.S. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. J. Clin. Endocrinol. Metab. 1995, 80:2410-2418.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 2410-2418
-
-
Laursen, T.1
Jørgensen, J.O.2
Jakobsen, G.3
Hansen, B.L.4
Christiansen, J.S.5
-
103
-
-
0035048752
-
Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults
-
Laursen T., Gravholt C.H., Heickendorff L., et al. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults. J. Clin. Endocrinol. Metab. 2001, 86:1222-1228.
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 1222-1228
-
-
Laursen, T.1
Gravholt, C.H.2
Heickendorff, L.3
-
104
-
-
40949136609
-
Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency
-
Clemmons D.R. Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency. Horm. Res. 2007, 68(Suppl. 5):178-181.
-
(2007)
Horm. Res.
, vol.68
, Issue.SUPPL. 5
, pp. 178-181
-
-
Clemmons, D.R.1
-
105
-
-
3242666740
-
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children
-
Kemp S., Fielder P.J., Attie K.M., et al. Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children. J. Clin. Endocrinol. Metab. 2004, 89:3234-3240.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 3234-3240
-
-
Kemp, S.1
Fielder, P.J.2
Attie, K.M.3
-
106
-
-
0036290740
-
A long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiency
-
Silverman B.L., Blethen S.L., Reiter E.O., Attie K.M., Neuwirth R.B., Ford K.M. A long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiency. J. Pediatr. Endocrinol. Metab. 2002, 15(Suppl. 2):715-722.
-
(2002)
J. Pediatr. Endocrinol. Metab.
, vol.15
, Issue.SUPPL. 2
, pp. 715-722
-
-
Silverman, B.L.1
Blethen, S.L.2
Reiter, E.O.3
Attie, K.M.4
Neuwirth, R.B.5
Ford, K.M.6
-
107
-
-
77954900288
-
Pegylated long-acting human growth hormone is well-tolerated in healthy subjects and possesses a potential once-weekly pharmacokinetic and pharmacodynamic treatment profile
-
Rasmussen M.H., Bysted B.V., Anderson T.W., Klitgaard T., Madsen J. Pegylated long-acting human growth hormone is well-tolerated in healthy subjects and possesses a potential once-weekly pharmacokinetic and pharmacodynamic treatment profile. J. Clin. Endocrinol. Metab. 2010, 95:3411-3417.
-
(2010)
J. Clin. Endocrinol. Metab.
, vol.95
, pp. 3411-3417
-
-
Rasmussen, M.H.1
Bysted, B.V.2
Anderson, T.W.3
Klitgaard, T.4
Madsen, J.5
-
108
-
-
78649237780
-
Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile
-
Rasmussen M.H., Jensen L., Anderson T.W., Klitgaard T., Madsen J. Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile. Clin. Endocrinol. (Oxf.) 2010, 73:769-776.
-
(2010)
Clin. Endocrinol. (Oxf.)
, vol.73
, pp. 769-776
-
-
Rasmussen, M.H.1
Jensen, L.2
Anderson, T.W.3
Klitgaard, T.4
Madsen, J.5
-
109
-
-
79952289185
-
Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with GH deficiency
-
Søndergaard E., Klose M., Hansen M., et al. Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with GH deficiency. J. Clin. Endocrinol. Metab. 2011, 96:681-688.
-
(2011)
J. Clin. Endocrinol. Metab.
, vol.96
, pp. 681-688
-
-
Søndergaard, E.1
Klose, M.2
Hansen, M.3
-
110
-
-
28744459194
-
Genentech adult growth hormone deficiency study group, efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency
-
Hoffman A.R., Biller B.M., Cook D., et al. Genentech adult growth hormone deficiency study group, efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J. Clin. Endocrinol. Metab. 2005, 90:6431-6440.
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, pp. 6431-6440
-
-
Hoffman, A.R.1
Biller, B.M.2
Cook, D.3
-
111
-
-
0030007487
-
Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis
-
Johansson J.O., Oscarsson J., Bjarnason R., Bengtsson B.A. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis. Metabolism 1996, 45:362-369.
-
(1996)
Metabolism
, vol.45
, pp. 362-369
-
-
Johansson, J.O.1
Oscarsson, J.2
Bjarnason, R.3
Bengtsson, B.A.4
-
112
-
-
0025292432
-
Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices
-
Jørgensen J.O., Møller N., Lauritzen T., Christiansen J.S. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices. J. Clin. Endocrinol. Metab. 1990, 70:1616-1623.
-
(1990)
J. Clin. Endocrinol. Metab.
, vol.70
, pp. 1616-1623
-
-
Jørgensen, J.O.1
Møller, N.2
Lauritzen, T.3
Christiansen, J.S.4
-
113
-
-
79957784185
-
French Acromegaly Registry. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
-
Fieffe S., Morange I., Petrossians P., et al. French Acromegaly Registry. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Eur. J. Endocrinol. 2011, 164:877-884.
-
(2011)
Eur. J. Endocrinol.
, vol.164
, pp. 877-884
-
-
Fieffe, S.1
Morange, I.2
Petrossians, P.3
-
114
-
-
1442326975
-
Systemic complications of acromegaly: epidemiology, pathogenesis, and management
-
Colao A., Ferone D., Marzullo P., Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 2004, 25:102-152.
-
(2004)
Endocr. Rev.
, vol.25
, pp. 102-152
-
-
Colao, A.1
Ferone, D.2
Marzullo, P.3
Lombardi, G.4
-
115
-
-
0029119736
-
Continuous infusion versus daily injections of growth hormone (GH) for four weeks in GH-deficient patients
-
Laursen T., Jørgensen J.O.L., Jakobsen G., Hansen B.L., Christiansen J.S. Continuous infusion versus daily injections of growth hormone (GH) for four weeks in GH-deficient patients. J. Clin. Endocrinol. Metab. 1995, 80:2410-2418.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 2410-2418
-
-
Laursen, T.1
Jørgensen, J.O.L.2
Jakobsen, G.3
Hansen, B.L.4
Christiansen, J.S.5
-
116
-
-
0035048752
-
Long-term effects of continuous subcutaneous (sc) infusion versus daily injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, bone and lipoprotein metabolism in GH-deficient adults
-
Laursen T., Gravholt C.H., Heickendorff L., et al. Long-term effects of continuous subcutaneous (sc) infusion versus daily injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, bone and lipoprotein metabolism in GH-deficient adults. J. Clin. Endocrinol. Metab. 2001, 86:1222-1228.
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 1222-1228
-
-
Laursen, T.1
Gravholt, C.H.2
Heickendorff, L.3
-
118
-
-
0033020408
-
Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board
-
Cutfield W., Lindberg A., Albertsson Wikland K., Chatelain P., Ranke M.B., Wilton P. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board. Acta Paediatr. Suppl. 1999, 88:72-75.
-
(1999)
Acta Paediatr. Suppl.
, vol.88
, pp. 72-75
-
-
Cutfield, W.1
Lindberg, A.2
Albertsson Wikland, K.3
Chatelain, P.4
Ranke, M.B.5
Wilton, P.6
-
119
-
-
7944239392
-
Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiency
-
Cole T.J., Hindmarsh P.C., Dunger D.B. Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiency. Arch. Dis. Child. 2004, 89:1024-1027.
-
(2004)
Arch. Dis. Child.
, vol.89
, pp. 1024-1027
-
-
Cole, T.J.1
Hindmarsh, P.C.2
Dunger, D.B.3
-
120
-
-
16344387901
-
Patient outcomes in the GH Monitor: the effect of delivery device on compliance and growth
-
Desrosiers P., O'Brien F., Blethen S. Patient outcomes in the GH Monitor: the effect of delivery device on compliance and growth. Pediatr. Endocrinol. Rev. 2005, 2(Suppl. 3):327-331.
-
(2005)
Pediatr. Endocrinol. Rev.
, vol.2
, Issue.SUPPL. 3
, pp. 327-331
-
-
Desrosiers, P.1
O'Brien, F.2
Blethen, S.3
-
121
-
-
38849149862
-
Monitoring of concordance in growth hormone therapy
-
Kapoor R.R., Burke S.A., Sparrow S.E., et al. Monitoring of concordance in growth hormone therapy. Arch. Dis. Child. 2008, 93:147-148.
-
(2008)
Arch. Dis. Child.
, vol.93
, pp. 147-148
-
-
Kapoor, R.R.1
Burke, S.A.2
Sparrow, S.E.3
-
122
-
-
0942266135
-
Long-term outcome of growth hormone therapy in children and adolescents
-
Lanes R. Long-term outcome of growth hormone therapy in children and adolescents. Treat. Endocrinol. 2004, 3:53-66.
-
(2004)
Treat. Endocrinol.
, vol.3
, pp. 53-66
-
-
Lanes, R.1
-
124
-
-
45849125438
-
Compliance and persistence in pediatric and adult patients receiving growth hormone therapy
-
Rosenfeld R.G., Bakker B. Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr. Pract. 2008, 14:143-154.
-
(2008)
Endocr. Pract.
, vol.14
, pp. 143-154
-
-
Rosenfeld, R.G.1
Bakker, B.2
-
125
-
-
41549148182
-
Observations of nonadherence to recombinant human growth hormone therapy in clinical practice
-
Haverkamp F., Johansson L., Dumas H., et al. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice. Clin. Ther. 2008, 30:307-316.
-
(2008)
Clin. Ther.
, vol.30
, pp. 307-316
-
-
Haverkamp, F.1
Johansson, L.2
Dumas, H.3
-
126
-
-
33845405556
-
Inhaled insulin (Exubera): combining efficacy and convenience
-
Bellary S., Barnett A.H. Inhaled insulin (Exubera): combining efficacy and convenience. Diab. Vasc. Dis. Res. 2006, 3:179-185.
-
(2006)
Diab. Vasc. Dis. Res.
, vol.3
, pp. 179-185
-
-
Bellary, S.1
Barnett, A.H.2
-
127
-
-
0033258165
-
Norditropin® SimpleXx- a liquid human growth hormone formulation, a pen system and an auto-insertion device
-
Müller J., Skakkebaek N.E., Jacobsen B., et al. Norditropin® SimpleXx-: a liquid human growth hormone formulation, a pen system and an auto-insertion device. Horm. Res. 1999, 51(Suppl. 3):109-112.
-
(1999)
Horm. Res.
, vol.51
, Issue.SUPPL. 3
, pp. 109-112
-
-
Müller, J.1
Skakkebaek, N.E.2
Jacobsen, B.3
-
128
-
-
0034956581
-
An open-label acceptability study of Norditropin SimpleXx - a new liquid growth hormone formulation
-
Stanhope R., Buchanan C., Butler G., et al. An open-label acceptability study of Norditropin SimpleXx - a new liquid growth hormone formulation. J. Pediatr. Endocrinol. Metab. 2001, 14:735-740.
-
(2001)
J. Pediatr. Endocrinol. Metab.
, vol.14
, pp. 735-740
-
-
Stanhope, R.1
Buchanan, C.2
Butler, G.3
-
129
-
-
0036042720
-
Acceptability of liquid human growth hormone (hGH) (Norditropin SimpleXx) in adults and children with growth hormone deficiency and children with chronic renal disease
-
Drent M.L., Jakobsdottir S., van Wijk J., et al. Acceptability of liquid human growth hormone (hGH) (Norditropin SimpleXx) in adults and children with growth hormone deficiency and children with chronic renal disease. Clin. Drug Investig. 2002, 22:633-638.
-
(2002)
Clin. Drug Investig.
, vol.22
, pp. 633-638
-
-
Drent, M.L.1
Jakobsdottir, S.2
van Wijk, J.3
-
130
-
-
0035458278
-
Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin
-
Chan H. Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin. J. Adv. Nurs. 2001, 35:882-892.
-
(2001)
J. Adv. Nurs.
, vol.35
, pp. 882-892
-
-
Chan, H.1
-
131
-
-
33750602438
-
Understanding and meeting the needs of those using growth hormone injection devices
-
Dumas H., Panayiotopoulos P., Parker D., Pongpairochana V. Understanding and meeting the needs of those using growth hormone injection devices. BMC Endocr. Disord. 2006, 6:5.
-
(2006)
BMC Endocr. Disord.
, vol.6
, pp. 5
-
-
Dumas, H.1
Panayiotopoulos, P.2
Parker, D.3
Pongpairochana, V.4
-
133
-
-
80055087244
-
Double-blind study to compare the local tolerance of three different solutions used to reconstitute growth hormone (abstract)
-
Bridges A., Stirling H., McDowell J., et al. Double-blind study to compare the local tolerance of three different solutions used to reconstitute growth hormone (abstract). Presented at the British Pharmacological Society Meeting, London, England, December 18-19 1991.
-
(1991)
Presented at the British Pharmacological Society Meeting, London, England, December 18-19
-
-
Bridges, A.1
Stirling, H.2
McDowell, J.3
-
134
-
-
33645073012
-
Pain perception after subcutaneous injections of media containing different buffers
-
Laursen T., Hansen B., Fisker S. Pain perception after subcutaneous injections of media containing different buffers. Basic Clin. Pharmacol. Toxicol. 2006, 98:218-221.
-
(2006)
Basic Clin. Pharmacol. Toxicol.
, vol.98
, pp. 218-221
-
-
Laursen, T.1
Hansen, B.2
Fisker, S.3
-
135
-
-
0031845014
-
Pain perception following subcutaneous injections of citrate-buffered and phosphate-buffered epoetin alpha
-
Yu A.W., Leung C.B., Li P.K., et al. Pain perception following subcutaneous injections of citrate-buffered and phosphate-buffered epoetin alpha. Int. J. Artif. Organs 1998, 21:341-343.
-
(1998)
Int. J. Artif. Organs
, vol.21
, pp. 341-343
-
-
Yu, A.W.1
Leung, C.B.2
Li, P.K.3
-
136
-
-
0031745277
-
Multicentre survey on compliance with growth hormone therapy: what can be improved?
-
Oyarzabal M., Aliaga M., Chueca M., Echarte G., Ulied A. Multicentre survey on compliance with growth hormone therapy: what can be improved?. Acta Paediatr. 1998, 87:387-391.
-
(1998)
Acta Paediatr.
, vol.87
, pp. 387-391
-
-
Oyarzabal, M.1
Aliaga, M.2
Chueca, M.3
Echarte, G.4
Ulied, A.5
-
137
-
-
80055079375
-
The perception of pain after subcutaneous injection of five different medias containing different solutions for use in the dissolution human growth homone (GH) in healthy volunteers
-
Hansen B., Bojesen A., Laursen T. The perception of pain after subcutaneous injection of five different medias containing different solutions for use in the dissolution human growth homone (GH) in healthy volunteers. Horm. Res. 2002, 58(Suppl. 2):106.
-
(2002)
Horm. Res.
, vol.58
, Issue.SUPPL. 2
, pp. 106
-
-
Hansen, B.1
Bojesen, A.2
Laursen, T.3
|